Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Waran Seri I ITSEC Asia Tbk. (CYBR-W) vs UBC Medical Indonesia Tbk. (LABS)

Waran Seri I ITSEC Asia Tbk.Trading
UBC Medical Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Waran Seri I ITSEC Asia Tbk. dan UBC Medical Indonesia Tbk.: Waran Seri I ITSEC Asia Tbk. diperdagangkan di Rp364 (kapitalisasi pasar 154,98 M, volume 24 jam 800), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 4,1× kapitalisasi pasar Waran Seri I ITSEC Asia Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (843 rb vs 800). Mana yang lebih baik tergantung tujuan investasimu.

CYBR-WLABS
Kapitalisasi Pasar
154,98 M635,95 M
Volume
800843 rb
Lot
88,43 rb
Perputaran
291,8 rb137,6 jt
Harga Rata-rata
364,75163,22
Nilai Transaksi
291,8 rb137,6 jt
Harga Ekuilibrium Indikatif
165
Volume Ekuilibrium Indikatif
246

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LABS
Lihat detail

Tentang Waran Seri I ITSEC Asia Tbk.

PT ITSEC Asia Tbk (the “Company”) was established based on Notarial Deed No. 7 dated April 12, 2010 of Refizal, S.H., M.Hum., notary in Jakarta. The Company started its commercial operations in 2010.

Selengkapnya di halaman CYBR-W

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS